Juan Gu

792 total citations
50 papers, 585 citations indexed

About

Juan Gu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Juan Gu has authored 50 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Oncology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Juan Gu's work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Protein Degradation and Inhibitors (10 papers). Juan Gu is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Protein Degradation and Inhibitors (10 papers). Juan Gu collaborates with scholars based in United States, China and Germany. Juan Gu's co-authors include Francisco J. Hernandez‐Ilizaliturri, Cory Mavis, Myron S. Czuczman, Nancy S. Magnuson, Zeping Wang, Matthew J. Barth, Raymond Reeves, Qunling Zhang, Kai Xue and Ye Guo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Juan Gu

45 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Gu United States 14 374 229 184 72 62 50 585
Ranjana Tavorath United States 8 285 0.8× 166 0.7× 86 0.5× 52 0.7× 37 0.6× 11 562
Chaitanya Iragavarapu United States 8 213 0.6× 138 0.6× 78 0.4× 33 0.5× 62 1.0× 15 392
Shaun Grosskurth United States 10 307 0.8× 123 0.5× 103 0.6× 50 0.7× 38 0.6× 18 445
Jennifer K. Taylor United States 6 337 0.9× 120 0.5× 77 0.4× 34 0.5× 137 2.2× 7 550
Joanna M. Lubieniecka Canada 13 272 0.7× 136 0.6× 74 0.4× 54 0.8× 37 0.6× 22 519
Christelle M. Rodrigue France 11 211 0.6× 141 0.6× 83 0.5× 72 1.0× 28 0.5× 17 454
Na Chen China 13 223 0.6× 119 0.5× 97 0.5× 75 1.0× 20 0.3× 35 500
Song Shan China 9 304 0.8× 188 0.8× 69 0.4× 29 0.4× 48 0.8× 25 451
Qing-Rong Chen United States 9 289 0.8× 105 0.5× 54 0.3× 93 1.3× 30 0.5× 9 484
Flora Luo United States 7 205 0.5× 100 0.4× 62 0.3× 47 0.7× 23 0.4× 9 390

Countries citing papers authored by Juan Gu

Since Specialization
Citations

This map shows the geographic impact of Juan Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Gu more than expected).

Fields of papers citing papers by Juan Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Gu. The network helps show where Juan Gu may publish in the future.

Co-authorship network of co-authors of Juan Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Gu. A scholar is included among the top collaborators of Juan Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Gu. Juan Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Hua, Desheng Zhang, Jia Luo, et al.. (2025). Parallel and Visual Detections of ASFV by CRISPR-Cas12a and CRISPR-Cas13a Systems Targeting the Viral S273R Gene. Animals. 15(13). 1902–1902.
2.
Sundaram, Suchitra, Cory Mavis, Juan Gu, et al.. (2024). Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia. Leukemia & lymphoma. 65(14). 2129–2137.
3.
Ji, Dongmei, Shiyu Jiang, Qunling Zhang, et al.. (2023). Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor. Clinical and Translational Science. 16(8). 1396–1407. 1 indexed citations
4.
Mavis, Cory, Juan Gu, Scott H. Olejniczak, et al.. (2023). Mitochondrial Reprogramming By Bcl-2 Inhibitor Venetoclax Enhances αCD19 CAR-T Cell Fitness and Anti-Tumor Efficacy. Blood. 142(Supplement 1). 6845–6845. 2 indexed citations
5.
Torka, Pallawi, Tara A. Russell, Cory Mavis, et al.. (2023). AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas. Leukemia & lymphoma. 64(6). 1175–1185. 1 indexed citations
6.
Gu, Juan, et al.. (2023). Novel Drug to Target HK2 Overcomes Therapeutic Resistance in Preclinical B-Cell Lymphoma Models. Blood. 142(Supplement 1). 5793–5793.
7.
Sun, Qi, Ying Ye, Xiaoting Sun, et al.. (2022). MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma. Cancer Letters. 537. 215678–215678. 12 indexed citations
8.
Xue, Kai, Jichuan Wu, Ran Li, et al.. (2021). Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma. Cell Death and Disease. 12(10). 900–900. 18 indexed citations
9.
Gu, Juan, Pallawi Torka, Cory Mavis, et al.. (2021). Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy. Blood. 138(Supplement 1). 1340–1340. 1 indexed citations
10.
Singh, Anil, Juan Gu, Qunling Zhang, et al.. (2020). Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma. SHILAP Revista de lepidopterología. 8(1). 10–10. 25 indexed citations
11.
12.
Mavis, Cory, Pallawi Torka, Priyank Patel, et al.. (2017). Pre-Clinical Development of Targeted Therapies for Double Hit (DH) Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 130. 1542–1542. 1 indexed citations
13.
14.
Gu, Juan, Anil Singh, Kai Xue, et al.. (2017). Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development. Oncotarget. 9(3). 4020–4033. 42 indexed citations
15.
Gao, Shegan, Ruimin Liu, Yungang Zhao, et al.. (2016). Integrative topological analysis of mass spectrometry data reveals molecular features with clinical relevance in esophageal squamous cell carcinoma. Scientific Reports. 6(1). 21586–21586. 5 indexed citations
16.
17.
Xue, Kai, Juan Gu, Qunling Zhang, et al.. (2015). Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents. Journal of Cancer Research and Clinical Oncology. 142(2). 379–387. 73 indexed citations
18.
19.
Wang, Zeping, Yandong Zhang, Juan Gu, et al.. (2010). Pim-2 phosphorylation of p21Cip1/WAF1 enhances its stability and inhibits cell proliferation in HCT116 cells. The International Journal of Biochemistry & Cell Biology. 42(6). 1030–1038. 33 indexed citations
20.
Gu, Juan, Zeping Wang, Raymond Reeves, & Nancy S. Magnuson. (2009). PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene. 28(48). 4261–4271. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ranjana Tavorath Breakdown of academic impact, for papers by Chaitanya Iragavarapu Breakdown of academic impact, for papers by Shaun Grosskurth Breakdown of academic impact, for papers by Jennifer K. Taylor Breakdown of academic impact, for papers by Joanna M. Lubieniecka Breakdown of academic impact, for papers by Christelle M. Rodrigue Breakdown of academic impact, for papers by Na Chen Breakdown of academic impact, for papers by Song Shan Breakdown of academic impact, for papers by Qing-Rong Chen Breakdown of academic impact, for papers by Flora Luo
Rankless by CCL
2026